London, United Kingdom

Jorn Lakowski

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ucl Business Plc. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jorn Lakowski. Retrieved from https://idiyas.com/inventor/jorn-lakowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jorn Lakowski: Innovator in Photoreceptor Identification

Introduction

Jorn Lakowski is a notable inventor based in London, GB. He has made significant contributions to the field of photoreceptor identification, particularly in relation to retinal health and treatment.

Latest Patents

Lakowski holds a patent titled "Method of identifying l/m-opsin and CRX positive cone photoreceptor cells based on specific biomarkers." This invention focuses on the identification of photoreceptors or cone photoreceptors in cell populations. The methods described in the patent are crucial for isolating these photoreceptors, which can be utilized for transplantation and the treatment of retinal dystrophies. Additionally, the patent claims human cell populations enriched for photoreceptors and kits designed for their identification. He has 1 patent to his name.

Career Highlights

Jorn Lakowski is associated with UCL Business Plc, where he continues to advance his research and innovations in the field of photoreceptors. His work has the potential to significantly impact the treatment of retinal diseases.

Collaborations

Lakowski has collaborated with esteemed colleagues such as Jane Sowden and Robin Ali, contributing to the advancement of research in photoreceptor identification.

Conclusion

Jorn Lakowski's innovative work in identifying photoreceptors is paving the way for new treatments in retinal health. His contributions are vital for the future of photoreceptor research and therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…